Speaker illustration

Professor Jolanda van der Velden

VU University Medical Center, Institute for Cardiovascular Research (ICaRVU) , Amsterdam (Netherlands (The))

Member of:

European Society of Cardiology

Jolanda van der Velden, PhD, is chair of the Department for Physiology at the Amsterdam University Medical Center, and director of the Amsterdam Cardiovascular Sciences Institute. Since 2012 van der Velden is professor of the Netherlands Heart Institute. The main research interest of the van der Velden group is to study the role of sarcomere proteins in cardiac performance for which specific protein analyses and functional assays have been designed. As mutations in sarcomere proteins are a frequent cause of heart disease at young age, research on this topic was initiated with funding from European and prestigious national grants. The national research consotium (DOSIS) funded by the Netherlands Heart Foundation aims to study effects of genetic and environmental modifiers in cardiomyopathy. Studies on the genetic heart disease include basic cell and tissue analyses, which are combined with in vivo cardiovascular imaging in mouse models and human patients.

Young Investigator Awards Session in Basic Science

Event: ESC Congress 2021 - The Digital Experience

Topic: Basic Science

Session type: Award Sessions

Thumbnail

HFpEF: different mechanistic phenotypes require distinct therapeutic strategies

Event: ESC Congress 2021 - The Digital Experience

Topic: Basic Science

Session type: Symposium

Thumbnail

Congress committee e-posters choice in basic science

Event: ESC Congress 2021 - The Digital Experience

Topic: Basic Science

Session type: Congress Committee e-posters Choice

Thumbnail

Young Investigator Award Session Basic Science

Event: ESC CONGRESS 2019

Topic: Basic Science

Session type: Young Investigator Award Abstracts

Thumbnail

Meet the Gold Medalist - Christine Seidman

Event: ESC CONGRESS 2019

Topic: European Society of Cardiology, Other

Session type: Interview

Thumbnail

Mitochondria as an emerging target in cardiovascular disease

Event: ESC Congress 2018

Topic: Basic Science

Session type: Symposium

Thumbnail

Mechanisms of Heart Failure with preserved Ejection Fraction - Implications for treatment

Event: ESC CONGRESS 2017

Topic: Growth factors, neurohormones and signal transduction-cardiac

Session type: Symposium

Thumbnail

Novel insights into pathological cell signalling in cardiomyopathy

Event: ESC CONGRESS 2016

Topic: Integrative physiology and control mechanisms

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk